Back to news

The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination

PR Newswire•11/08/2026•08:30 ET
0
Whiz Insights

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in